News for September 2017

News Archive

Verseon developing oral treatment for hereditary angioedema

Drug candidates show good exposure suitable for oral dosingReduced swelling observed in the standard preclinical disease model for HAE

Scientists develop ultra fast method of changing fundamental property of light Scientists develop ultra fast method of changing fundamental property of light

Breakthrough in rapid polarisation switching could allow faster data transfer and open new areas of nano-researchNew material allows light wave properties to be rapidly changed using light itself, overcoming speed limitations of physical electronics

Medidata Opens New, Larger London EMEA Headquarters Medidata Opens New, Larger London EMEA Headquarters

Europe/EMEA Experiencing Rapid Growth, Expanded New Facilities to Meet Demand

DNAe Previews its Semiconductor Genomic Analysis Test to Address the Challenge of Sepsis DNAe Previews its Semiconductor Genomic Analysis Test to Address the Challenge of Sepsis

LiDia™ Bloodstream Infection (BSI) Test showcased at an Imperial College/Royal Institution Technology vs Infectious Diseases Summit, London

NTU scientists develop patch which could improve healing and reduce scarring NTU scientists develop patch which could improve healing and reduce scarring

Scientists from Nanyang Technological University, Singapore (NTU Singapore) have developed a new gel patch prototype that could speed up the healing of a skin wound while minimising the formation of scars. The team unveiled the patch today as a proof-of-concept.

The Current issue of “The view from here” is concerned with Novel Therapeutics. The Current issue of “The view from here” is concerned with Novel Therapeutics.

The topic of this month’s newsletter from Drug Discovery Today is Novel Therapeutics.

Prestigious scientific organisations support Lab Innovations Prestigious scientific organisations support Lab Innovations

Lab Innovations – the UK’s only dedicated showcase for laboratory, analytical and biotech equipment – continues to garner support from across the scientific community. Returning to the NEC, Birmingham, for the sixth consecutive year on the 1st and 2nd of November 2017, this year’s event will be backed by renowned organisations including the Science Council, Innovation DB and Laboratory News.

New Drug Discovery Alliance to Tackle High Rate of Failure in Drug Development New Drug Discovery Alliance to Tackle High Rate of Failure in Drug Development

Two prominent preclinical safety companies have launched a unique European alliance to address the high safety-related failure rate in drug development.

PureTech Health Exclusively Licenses Novel Milk-Derived Exosome Technology for Oral Administration of Biologics, Nucleic Acids, and Complex Small Molecules PureTech Health Exclusively Licenses Novel Milk-Derived Exosome Technology for Oral Administration of Biologics, Nucleic Acids, and Complex Small Molecules

PureTech Health plc , an advanced, clinical-stage biopharmaceutical company, today announced an exclusive licensing agreement with 3P Biotechnologies, Inc., via University of Louisville, for an exosome-based technology (Calix) for the oral administration of biologics, nucleic acids, and complex small molecules

Bacterial in-fighting provides new treatment for hospital infections Bacterial in-fighting provides new treatment for hospital infections

A bacterium that is a leading cause of death worldwide from hospital acquired infections following antibiotic treatment looks set to be brought down through its own sibling rivalry.

MR Solutions receives second Queen’s Award from Lord-Lieutenant of Surrey MR Solutions receives second Queen’s Award from Lord-Lieutenant of Surrey

MR Solutions has received the prestigious Queen’s Award for Enterprise from the Lord-Lieutenant of Surrey at their Guildford headquarters in September in recognition of their outstanding success in growing international sales. It was only a year earlier that MR Solutions had won the Queen’s Award for Enterprise for Innovation.